𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer

✍ Scribed by Tero A.H. Järvinen; Minna Tanner; Virpi Rantanen; Maarit Bärlund; Åke Borg; Seija Grénman; Jorma Isola

Book ID
117022465
Publisher
American Society for Investigative Pathology
Year
2000
Tongue
English
Weight
1010 KB
Volume
156
Category
Article
ISSN
0002-9440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of topoisomerase IIα ge
Characterization of topoisomerase IIα gene amplification and deletion in breast cancer
✍ Tero A.H. Järvinen; Minna Tanner; Maarit Bärlund; Åke Borg; Jorma Isola 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

Topoisomerase II␣ (TOP2A) is a key enzyme in DNA replication and a molecular target for many important anticancer drugs. TOP2A is amplified or deleted together with amplification of the closely located ERBB2/HER-2/neu oncogene in breast cancer. We characterized the copy number aberrations of TOP2A a

Topoisomerase II-α (topoII) and HER2 amp
Topoisomerase II-α (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapy
✍ K Park; J Kim; S Lim; S Han 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 101 KB

A significant proportion of breast cancers with HER2 amplification have simultaneous amplification of topoisomerase II-alpha (topoII). Amplification of HER2 and topoII was assayed using a novel chromogenic in situ hybridisation (CISH) method. HER2 and topoII amplification status and the response to